DCM
EDIT icon

DAFNA Capital Management’s Editas Medicine EDIT Stock Holding History

DAFNA Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$552K Buy
+170,470
New +$498K 0.11% 74

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

DAFNA Capital Management's EDIT Position: Q2 2026 in Review

DAFNA Capital Management opened a new position in Editas Medicine (EDIT) in Q2 2026: 170,470 shares worth $552K. The stake represents 0.11% of the portfolio and ranks #74 among its holdings.

214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • DAFNA Capital Management held 170,470 shares of Editas Medicine worth $552K as of Q2 2026.
  • Editas Medicine was a new DAFNA Capital Management position in Q2 2026.
  • Editas Medicine made up 0.11% of DAFNA Capital Management's portfolio in Q2 2026, its #74 holding.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.